Inventor · disambiguated record
Ryan Dorton
Also filed as: DORTON RYAN
3 granted patents·10 pending applications·41 citations·filing 2013–2024
74Inventor score
Files withENDOCYTE INC13
Top patents by PatentIndex Score
13 records- 0194US9636413B2Conjugates for treating diseases caused by PSMA expressing cellsENDOCYTE INC·Filed 2013·Granted May 2, 2017·32 cites·10 claims
- 0291US10912840B2Conjugates for treating diseases caused by PSMA expressing cellsENDOCYTE INC·Filed 2018·Granted Feb 9, 2021·4 cites·5 claims
- 0389US2025170253A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2024·Application pending·0 cites
- 0488US9782493B2Conjugates for treating diseases caused by PSMA expressing cellsENDOCYTE INC·Filed 2016·Granted Oct 10, 2017·5 cites·19 claims
- 0580US2022265841A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2022·Application pending·0 cites
- 0675US2021154311A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2021·Application pending·0 cites
- 0775US2021154312A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2021·Application pending·0 cites
- 0869US2019314515A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2019·Application pending·0 cites
- 0966US2018289826A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2018·Application pending·0 cites
- 1066US2018271991A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2018·Application pending·0 cites
- 1164US2017258932A1Conjugates for treating diseases caused by psma expressing cellsENDOCYTE INC·Filed 2017·Application pending·0 cites
- 1243US2017348376A1Tubulysin conjugate for use in treating cancerENDOCYTE INC·Filed 2017·Application pending·0 cites
- 1333US2017290878A1Methods of treating cancer with tubulysin conjugatesENDOCYTE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryan Dorton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →